Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Whole-Body Cooling for Birth Asphyxia in Term Infants

ClinicalTrials.gov ID: NCT00005772

Public ClinicalTrials.gov record NCT00005772. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 5:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This large multicenter trial tested whether cerebral cooling initiated within 6 hours of birth and continued for 72 hours would reduce the risk of death and moderate to severe neurodevelopmental injury at 18-22 months corrected age. Infants at least 36 weeks gestation with an abnormal blood gas within 1 hour of birth, or a history of an acute perinatal event and a 10-min Apgar score \<5, or continued need for ventilation were screened. Following a neurological exam, those with moderate to severe encephalopathy were randomized to a 72-hour period of total body cooling (cooling blanket, followed by slow re-warming). The study was conducted in two phases: Phase I (20 infants) were examined for the safety of an esophageal temperature of 34-35 C; Phase II (main trial, 200 infants) were evaluated for the safety and efficacy of an esophageal temperature of 33-34 C. Cardio-respiratory, electroencephalograms (EEGs), renal, metabolic, and hematologic status, and esophageal and abdominal skin temperature were monitored during the 72 hours of intervention. Surviving children were given neurodevelopmental examinations at 18-22 months corrected age and again at school age (6-7 years of age).

Study identification

NCT ID
NCT00005772
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
208 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 6 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 1999
Primary completion
Apr 30, 2003
Completion
Jun 30, 2010
Last update posted
Mar 21, 2019

1999 – 2010

United States locations

U.S. sites
16
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Stanford University Palo Alto California 94304
Yale University New Haven Connecticut 06504
University of Miami Miami Florida 33136
Emory University Atlanta Georgia 30303
Indiana University Indianapolis Indiana 46202
Harvard University Cambridge Massachusetts 02138
Wayne State University Detroit Michigan 48201
University of New Mexico Albuquerque New Mexico 87131
RTI International Durham North Carolina 27705
Cincinnati Children's Medical Center Cincinnati Ohio 45267
Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland Ohio 44106
Brown University, Women & Infants Hospital of Rhode Island Providence Rhode Island 02905
University of Tennessee Memphis Tennessee 38163
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75235
University of Texas Health Science Center at Houston Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00005772, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2019 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005772 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →